BSE filing, NSE: INDGN. Summary written from the filing by ALFA Finder's alert engine.
Indegene Ltd: key numbers
- Share price
- ₹594.70
- Market cap
- ₹14,328 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 35.7×Sector 52.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indegene Ltd
All →Indegene Merger & Restructuring
Indegene Ltd disclosed that its step-down wholly owned subsidiary, Indegene Portugal Unipessoal LDA, was incorporated on 23 October 2026. The entity has nil turnover and is yet to begin operations.
Indegene Business Update
Indegene received Frost & Sullivan's 2026 Global Enabling Technology Leadership award for AI-powered pharma commercialization. The recognition highlights its domain-led AI platform and workflow transformation capabilities.
Indegene Other Announcement
Indegene Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing details share distribution across promoter and public shareholder categories.
Indegene Management Change
Indegene's Non-Executive Director Mr. Mark Dzialga resigned effective October 29, 2026, following Brighton Park Capital's sale of its entire stake. No other material board changes are disclosed.
Indegene Business Update
Indegene held its 2026 Digital Summit in Philadelphia, drawing 120+ pharma leaders and 19 speakers. The event showcased the company's AI-native pharma enablement capabilities.
Indegene Board Meeting Date
Indegene Limited scheduled a board meeting for October 29, 2026, to approve unaudited financial results and consider share allotments under ESOP and RSU schemes.
Other employee stock options announcements
All →Info Edge (India) Employee Stock Options
Info Edge's employee stock option trust sold 1,439 shares on 26 October 2026 under the ESOP scheme. The disposal reduces the trust's holding to 410,707 shares.
Motilal Oswal Financial Services Employee Stock Options
Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.
Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Coforge Employee Stock Options
Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.
Greenply Industries Employee Stock Options
Greenply Industries allotted 500 equity shares under its ESOP 2020 scheme on 29 October 2026. The allotment lifts paid-up capital to Rs.12,49,02,545.